Outlined companies are part of our initial Beta 2.0 expansion. We expect to initiate full coverage of all companies in 2024, depending on subscriber count.
Solt DB is a public benefit company exploring the business of biotech. For scientists, investors, and nerds of all stripes -- or feathers.
Please respect the finch n@. ©2024 Solt DB